Dr. Janet D. Rowley       Chronic Myeloid Leukemia     CML

Dr. Janet Davison Rowley (born in 1925)  is the first scientist to identify a chromosomal translocation as the cause of leukemia and other cancers.  Dr. Rowley made the breakthrough discovery in 1972 of two translocations in leukemia,  the 8:21 translocation in acute myelogenous leukemia (AML) and the 9:22 translocation in chronic myelogenous leukemia (CML).
  

VIDEOS


From Chromosomes To Cures: The Lifesaving Cancer Research Of Dr. Janet Rowley
February 21, 2013, Chicago Blood Cancer

Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert

Janet Rowley's Vision: Treating Cancer at the Molecular Level            
December 12, 2011, University of Chicago Medical Center

CML - Pathways to Discovery - Dr. Janet D. Rowley                               
September 22, 2011, National CML Society

Celebrating Janet D. Rowley, MD                                                 
December 15, 2019, University of Chicago Medical Center

Interview with Janet D. Rowley, M.D., D.Sc.                                    
April  18, 2010, AACRNews

Janet Rowley Receives Presidential Medal of Freedom for Cancer Chromosome Studies                   
October 9, 2009, UniversityChicagoMedicalCenter

ARTICLES

Janet Rowley shares prestigious medical  prize with cancer treatment pioneers
April 17, 2013, UChicagoNews 

Named professorship to honor cancer researcher Janet Rowley, MD
May 24th, 2012, The University of Chicago Medicine

The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org

Dr. Janet D. Rowley
July 30,  2011, Sapana in Chicagoland

The Matriarch of Modern Cancer Genetics 
February 7, 2011,  The New York Times

                     

                                     Dr. Janet Davidson Rowley in Facebook

                                               See the history of CML